In the book-building process regaring Celon Pharma S.A.'s IPO which was completed today and was held by Mercurius Dom Maklerski, investors expressed their desire to purchase the Company's shares for over PLN 1.5 billion, including in the retail tranche almost 2.5 thousand investors offered to buy shares with the value of over PLN 180 million.
"Investors were enthusiastic about our Company's strategy and large numbers of them declared their willingness to buy the shares. It is also important in view of the fact that we are dealing with rather uncertain conditions in the capital market. This makes us even happier to be close to finalising our initial public offering which turned out to be such a success."says Maciej Wieczorek, President of the Management Board of Celon Pharma S.A.